# Niagen Bioscience, Inc.: Form 8-K, filed Dec 13, 2023

- Company: [Niagen Bioscience, Inc.](/companies/nage.md) (CIK 1386570)
- Form: 8-K
- Filed: 2023-12-13
- Accepted by EDGAR: Dec 13, 2023, 16:00 ET
- Period: 2023-12-08
- Accession: 0001628280-23-041428
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1386570/000162828023041428/cdxc-20231208.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1386570/000162828023041428/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1386570/000162828023041428/cdxc-20231208.htm

Filed Dec 13, 2023.
Source: SEC EDGAR, the filing index for accession 0001628280-23-041428. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.